Commentary on "Rethinking the International Response System to Global Health Threats: Strengthening International Collaboration to Ensure Vaccine Equity and Combat Vaccination Hesitancy".

2区 医学 Q1 Medicine Advances in Cancer Research Pub Date : 2022-03-01 DOI:10.14423/SMJ.0000000000001366
Steven T Baldwin
{"title":"Commentary on \"Rethinking the International Response System to Global Health Threats: Strengthening International Collaboration to Ensure Vaccine Equity and Combat Vaccination Hesitancy\".","authors":"Steven T Baldwin","doi":"10.14423/SMJ.0000000000001366","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":50875,"journal":{"name":"Advances in Cancer Research","volume":"47 1","pages":"168-174"},"PeriodicalIF":0.0000,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865028/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Cancer Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.14423/SMJ.0000000000001366","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
关于 "反思全球健康威胁的国际应对系统:加强国际合作,确保疫苗公平,消除疫苗接种犹豫 "的评论。
2019冠状病毒病(COVID-19)疫苗接种率仍不足以实现对严重急性呼吸综合征冠状病毒2 (SARS-CoV-2)病毒的全球群体免疫。主要有两个问题。许多国家希望通过大规模接种针对SARS-CoV-2病毒的疫苗来实现群体免疫,但没有资源这样做。这些国家可能有大量的自愿武器供应,但没有足够的疫苗剂量和(或)分配和管理所需疫苗剂量以实现群体免疫所需的其他资源供应。具有讽刺意味的是,许多资源丰富的国家,特别是美国,有充足的疫苗供应,但愿意接种疫苗的人数有限。也许现在是时候停止等待资源丰富的国家有更多的人接受COVID-19疫苗接种,并将更多努力集中在无法获得COVID-19疫苗的资源有限国家的大量人口身上。通过更快地提高世界上更多人口的疫苗接种率,而不是无限期地等待不接受疫苗的人改变他们的行为,这种方法可能会为COVID-19疫苗剂量带来更大的边际价值。已提出实现社区或国家人口接种率>80%是实现群体免疫的必要疫苗接种流行阈值。到目前为止,
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Advances in Cancer Research
Advances in Cancer Research 医学-肿瘤学
CiteScore
10.00
自引率
0.00%
发文量
52
期刊介绍: Advances in Cancer Research (ACR) has covered a remarkable period of discovery that encompasses the beginning of the revolution in biology. Advances in Cancer Research (ACR) has covered a remarkable period of discovery that encompasses the beginning of the revolution in biology. The first ACR volume came out in the year that Watson and Crick reported on the central dogma of biology, the DNA double helix. In the first 100 volumes are found many contributions by some of those who helped shape the revolution and who made many of the remarkable discoveries in cancer research that have developed from it.
期刊最新文献
Hereditary diffuse gastric cancer. Mass spectrometry based biomarkers for early detection of HCC using a glycoproteomic approach. Targeting the super elongation complex for oncogenic transcription driven tumor malignancies: Progress in structure, mechanisms and small molecular inhibitor discovery. Targeting epigenetic regulation for cancer therapy using small molecule inhibitors. Collaborative Spirit Drives the Field of Tumor Glycobiology: A Preface to Special Volume on Cancer Glycobiology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1